R. S. Fisher, C. Acevedo, A. Arzimanoglou, A. Bogacz, J. H. Cross et al., ILAE Official Report: A practical clinical definition of epilepsy, Epilepsia, vol.55, issue.4, pp.475-82, 2014.

, Organisation Mondiale de la Santé (OMS). (Page consultée le 15/06/2020)

, Organisation Mondiale de la Santé (OMS). (Page consultée le 15/06/2020). Principaux repères sur la dépression

C. Hoppe, Citing Hippocrates on depression in epilepsy, Epilepsy Behav. 1 janv, vol.90, pp.31-37, 2019.

E. S. Krishnamoorthy, M. R. Trimble, and D. Blumer, The classification of neuropsychiatric disorders in epilepsy: A proposal by the ILAE Commission on Psychobiology of Epilepsy, Epilepsy Behav. 1 mai, vol.10, issue.3, pp.349-53, 2007.

G. A. Baker, A. Jacoby, D. Buck, J. Brooks, P. Potts et al., The quality of life of older people with epilepsy: findings from a UK community study, Seizure. 1 mars, vol.10, issue.2, pp.92-101, 2001.

A. Ettinger, M. Reed, and J. Cramer, Depression and comorbidity in community-based patients with epilepsy or asthma, Neurology. 28 sept, vol.63, issue.6, pp.1008-1022, 2004.

S. A. Mensah, J. M. Beavis, A. K. Thapar, and M. Kerr, The presence and clinical implications of depression in a community population of adults with epilepsy, Epilepsy Behav. 1 févr, vol.8, issue.1, pp.213-222, 2006.

S. Stefanello, L. Marín-léon, P. T. Fernandes, L. M. Li, and N. J. Botega, Psychiatric comorbidity and suicidal behavior in epilepsy: A community-based case-control study, Epilepsia, vol.51, issue.7, pp.1120-1125, 2010.

K. Margrove, S. Mensah, A. Thapar, and M. Kerr, Depression screening for patients with epilepsy in a primary care setting using the Patient Health Questionnaire-2 and the Neurological Disorders Depression Inventory for Epilepsy, Epilepsy Behav EB. août, vol.21, issue.4, pp.387-90, 2011.

C. L. Peterson, C. Walker, and G. Shears, The social context of anxiety and depression: Exploring the role of anxiety and depression in the lives of Australian adults with epilepsy, Epilepsy Behav. 1 mai, vol.34, pp.29-33, 2014.

A. B. Ettinger, M. B. Good, R. Manjunath, E. Faught, R. Bancroft et al., The relationship of depression to antiepileptic drug adherence and quality of life in epilepsy, Epilepsy Behav. 1 juill, vol.36, pp.138-181, 2014.

A. Bulloch, K. M. Fiest, J. Williams, D. H. Lavorato, S. A. Berzins et al., Depressiona common disorder across a broad spectrum of neurological conditions: a cross-sectional nationally representative survey, Gen Hosp Psychiatry, vol.37, issue.6, pp.507-519, 2015.

C. J. Lacey, M. R. Salzberg, D. Souza, and W. J. , What factors contribute to the risk of depression in epilepsy?-Tasmanian Epilepsy Register Mood Study (TERMS), Epilepsia, vol.57, issue.3, pp.516-538, 2016.

H. Wang, Prevalence and risk factors of depression and anxiety among patients with convulsive epilepsy in rural West China -Wang -2018 -Acta Neurologica Scandinavica -Wiley Online Library, 2018.

M. R. Mohammadi, A. Ghanizadeh, H. Davidian, M. Mohammadi, and M. Norouzian, Prevalence of epilepsy and comorbidity of psychiatric disorders in Iran. Seizure, vol.15, pp.476-82, 2006.

J. F. Tellez-zenteno, S. B. Patten, N. Jetté, J. Williams, and S. Wiebe, Psychiatric Comorbidity in Epilepsy: A Population-Based Analysis, Epilepsia. 1 déc, vol.48, issue.12, pp.2336-2380, 2007.

E. Fuller-thomson and S. Brennenstuhl, The association between depression and epilepsy in a nationally representative sample, Epilepsia. 1 mai, vol.50, issue.5, pp.1051-1059, 2009.

D. Rai, M. P. Kerr, S. Mcmanus, V. Jordanova, G. Lewis et al., Epilepsy and psychiatric comorbidity: A nationally representative population-based study, Epilepsia. 1 juin, vol.53, issue.6, pp.1095-103, 2012.

P. Nubukpo, P. M. Preux, D. Houinato, A. Radji, E. K. Grunitzky et al., Psychosocial issues in people with epilepsy in Togo and Benin (West Africa) I. Anxiety and depression measured using Goldberg's scale, Epilepsy Behav, vol.5, issue.5, pp.722-729, 2004.

A. Gaitatzis, K. Carroll, A. Majeed, and J. W. Sander, The Epidemiology of the Comorbidity of Epilepsy in the General Population, Epilepsia. 1 déc, vol.45, issue.12, pp.1613-1635, 2004.

R. Kobau, F. Gilliam, and D. J. Thurman, Prevalence of Self-Reported Epilepsy or Seizure Disorder and Its Associations with Self-Reported Depression and Anxiety: Results from the 2004 Healthstyles Survey, Epilepsia, vol.47, issue.11, pp.1915-1936, 2006.

R. Ottman, R. B. Lipton, A. B. Ettinger, J. A. Cramer, M. L. Reed et al., Comorbidities of epilepsy: Results from the Epilepsy Comorbidities and Health (EPIC) survey, Epilepsia. 1 févr, vol.52, issue.2, pp.308-323, 2011.

E. Beghi, P. Spagnoli, L. Airoldi, E. Fiordelli, I. Appollonio et al., Emotional and affective disturbances in patients with epilepsy, Epilepsy Behav. 1 juin, vol.3, issue.3, pp.255-61, 2002.

H. Attarian, V. Vahle, J. Carter, E. Hykes, and F. Gilliam, Relationship between depression and intractability of seizures, Epilepsy Behav. 1 juin, vol.4, issue.3, pp.298-301, 2003.

V. K. Kimiskidis, N. I. Triantafyllou, E. Kararizou, S. Gatzonis, K. N. Fountoulakis et al., Depression and anxiety in epilepsy: the association with demographic and seizure-related variables. Ann Gen Psychiatry, vol.6, p.28, 2007.

O. Kwon and S. Park, What is the role of depressive symptoms among other predictors of quality of life in people with well-controlled epilepsy on monotherapy?, Epilepsy Behav. 1 mars, vol.20, issue.3, pp.528-560, 2011.

O. Kwon and S. Park, Frequency of affective symptoms and their psychosocial impact in Korean people with epilepsy: A survey at two tertiary care hospitals, Epilepsy Behav. 1 janv, vol.26, issue.1, pp.51-57, 2013.

H. Hecimovic, J. M. Santos, J. Carter, H. P. Attarian, A. J. Fessler et al., Depression but not seizure factors or quality of life predicts suicidality in epilepsy, Epilepsy Behav EB. août, vol.24, issue.4, pp.426-435, 2012.

. Tsegabrhan, Co-morbidity of depression and epilepsy in Jimma University specialized hospital, Neurol India, 2014.

B. B. Bifftu, B. A. Dachew, and B. T. Tiruneh, Birhan Tebeje N. Depression among people with epilepsy in Northwest Ethiopia: a cross-sectional institution based study, BMC Res Notes, vol.8, issue.1, p.585, 2015.

S. Kim, S. Park, and O. Kwon, Impact of depression and anxiety on adverse event profiles in Korean people with epilepsy, Epilepsy Behav. 1 mai, vol.46, pp.185-91, 2015.

M. Bosak, W. Turaj, D. Dudek, M. Siwek, and A. Szczudlik, Depressogenic medications and other risk factors for depression among Polish patients with epilepsy, Neuropsychiatr Dis Treat. 30 sept, vol.11, pp.2509-2526, 2015.

Y. Guo, X. Ding, R. Lu, C. Shen, Y. Ding et al., Depression and anxiety are associated with reduced antiepileptic drug adherence in Chinese patients, Epilepsy Behav. 1 sept, vol.50, pp.91-96, 2015.

C. R. Camara-lemarroy, M. Hoyos, B. E. Ibarra-yruegas, M. A. Díaz-torres, D. León et al., Affective symptoms and determinants of health-related quality of life in Mexican people with epilepsy, Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol, vol.38, issue.10, pp.1829-1863, 2017.

S. Choi-kwon, C. Chung, H. Kim, S. Lee, S. Yoon et al., Factors affecting the quality of life in patients with epilepsy in Seoul, South Korea, Acta Neurol Scand, vol.108, issue.6, pp.428-462, 2003.

K. S. Mosaku, F. O. Fatoye, M. Komolafe, M. Lawal, and B. A. Ola, Quality of life and associated factors among adults with epilepsy in Nigeria, Int J Psychiatry Med, vol.36, issue.4, pp.469-81, 2006.

M. T. Tegegne, Depression and anxiety disorder among epileptic people at Amanuel Specialized Mental Hospital, 2015.

H. Chen, Y. Tsai, M. Hsi, and J. Chen, Factors affecting quality of life in adults with epilepsy in Taiwan: A cross-sectional, correlational study, Epilepsy Behav. 1 mai, vol.58, pp.26-32, 2016.

R. Dias, L. M. Bateman, S. T. Farias, C. Li, T. Lin et al., Depression in epilepsy is associated with lack of seizure control, Epilepsy Behav, vol.19, issue.3, pp.445-452, 2010.

H. Azuma and T. Akechi, Effects of psychosocial functioning, depression, seizure frequency, and employment on quality of life in patients with epilepsy, Epilepsy Behav. 1 déc, vol.41, pp.18-20, 2014.

Q. Li, D. Chen, L. Zhu, H. Wang, D. Xu et al., Depression in people with epilepsy in West China: Status, risk factors and treatment gap, Seizure. mars, vol.66, pp.86-92, 2019.

C. Vallée, A. Biraben, A. Nica, and M. Loiseau, Épidémiologie et facteurs associés au syndrome dépressif chez les patients suivis au centre hospitalo-universitaire de Rennes pour une épilepsie, L'Encéphale. 1 févr, vol.45, issue.1, pp.40-45, 2019.

N. A. Seminario, S. T. Farias, J. Jorgensen, J. A. Bourgeois, and M. Seyal, Determination of prevalence of depression in an epilepsy clinic using a brief DSM-IV-based self-report questionnaire, Epilepsy Behav. juill, vol.15, issue.3, pp.362-368, 2009.

L. Jehi, G. Tesar, N. Obuchowski, E. Novak, and I. Najm, Quality of life in 1931 adult patients with epilepsy: Seizures do not tell the whole story, Epilepsy Behav. 1 déc, vol.22, issue.4, pp.723-730, 2011.

T. Alsaadi, E. Hammasi, K. Shahrour, T. M. Shakra, M. Turkawi et al., Prevalence of depression and anxiety among patients with epilepsy attending the epilepsy clinic at Sheikh Khalifa Medical City, UAE: A cross-sectional study, Epilepsy Behav, vol.52, pp.194-203, 2015.

A. C. Viguera, Y. Fan, N. R. Thompson, B. Lapin, A. Chaitoff et al., Prevalence and Predictors of Depression Among Patients With Epilepsy, Stroke, and Multiple Sclerosis Using the Cleveland Clinic Knowledge Program Within the Neurological Institute, Psychosomatics. 1 juill, vol.59, issue.4, pp.369-78, 2018.

E. Siarava, T. Hyphantis, A. H. Katsanos, S. Pelidou, A. P. Kyritsis et al., Depression and quality of life in patients with epilepsy in Northwest Greece, Seizure. mars, vol.66, pp.93-101, 2019.

J. E. Jones, B. P. Hermann, J. J. Barry, F. Gilliam, A. M. Kanner et al., Clinical Assessment of Axis I Psychiatric Morbidity in Chronic Epilepsy: A Multicenter Investigation, J Neuropsychiatry Clin Neurosci. 1 mai, vol.17, issue.2, pp.172-181, 2005.

D. Gülpek, E. Bolat, L. Mete, S. Arici, and M. Celebisoy, Psychiatric comorbidity, quality of life and social support in epileptic patients, Nord J Psychiatry. déc, vol.65, issue.6, pp.373-80, 2011.

M. Mula, A. Iudice, L. Neve, A. Mazza, M. Bartolini et al., Validation of the Italian version of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E), Epilepsy Behav. 1 juill, vol.24, issue.3, pp.329-360, 2012.

S. Mohamed, J. S. Gill, and C. T. Tan, Quality of life of patients with epilepsy in Malaysia, Asia-Pac Psychiatry, vol.6, issue.1, pp.105-114, 2014.

M. Gandy, L. Sharpe, K. N. Perry, L. Miller, Z. Thayer et al., Assessing the efficacy of 2 screening measures for depression in people with epilepsy, Neurology. 24 juill, vol.79, issue.4, pp.371-376, 2012.

P. Ko, J. Hwang, H. Lim, and S. Park, Reliability and validity of the Korean version of the Neurological Disorders Depression Inventory for Epilepsy (K-NDDI-E), Epilepsy Behav. 1 déc, vol.25, issue.4, pp.539-581, 2012.

D. Capua, D. , G. Me, A. Reig-ferrer, M. Fuentes-ferrer et al., Validation of the Spanish version of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E), Epilepsy Behav. 1 août, vol.24, issue.4, pp.493-499, 2012.

Y. Tadokoro, T. Oshima, T. Fukuchi, A. M. Kanner, and K. Kanemoto, Screening for major depressive episodes in Japanese patients with epilepsy: Validation and translation of the Japanese version of Neurological Disorders Depression Inventory for Epilepsy (NDDI-E), Epilepsy Behav. 1 sept, vol.25, issue.1, pp.18-22, 2012.

A. Al-asmi, A. Dorvlo, D. T. Burke, S. Al-adawi, A. et al., The detection of mood and anxiety in people with epilepsy using two-phase designs: Experiences from a tertiary care centre in Oman, Epilepsy Res. 1 févr, vol.98, issue.2, pp.174-81, 2012.

K. M. Fiest, S. B. Patten, S. Wiebe, A. Bulloch, C. J. Maxwell et al., Validating screening tools for depression in epilepsy, Epilepsia, vol.55, issue.10, pp.1642-50, 2014.

G. Amruth, S. Praveen-kumar, B. Nataraju, and P. Kasturi, Study of psychiatric comorbidities in epilepsy by using the Mini International Neuropsychiatric Interview, Epilepsy Behav. 1 avr, vol.33, pp.94-100, 2014.

P. Zis, P. Yfanti, A. Siatouni, A. Tavernarakis, and S. Gatzonis, Determinants of depression among patients with epilepsy in Athens, Greece. Epilepsy Behav. 1 avr, vol.33, pp.106-115, 2014.

G. N. De-oliveira, J. Lessa, A. P. Gonçalves, E. J. Portela, J. W. Sander et al., Screening for depression in people with epilepsy: Comparative study among Neurological Disorders Depression Inventory for Epilepsy (NDDI-E), Hospital Anxiety and Depression Scale Depression Subscale (HADS-D), and Beck Depression Inventory (BDI), Epilepsy Behav. 1 mai, vol.34, pp.50-54, 2014.

A. E. Thomson, A. Calle, M. E. Fontela, L. Yepez, F. M. Giacomelli et al., Screening of major depression in epilepsy: The Neurologic Depression Disorders Inventory in Epilepsy-Spanish version (Argentina), Epilepsia, vol.55, issue.2, pp.331-335, 2014.

J. S. Rathore, L. E. Jehi, Y. Fan, S. I. Patel, N. Foldvary-schaefer et al., Validation of the Patient Health Questionnaire-9 (PHQ-9) For Depression Screening in Adults with Epilepsy, Epilepsy Behav EB. août, vol.37, pp.215-235, 2014.

M. S. Wiglusz, J. Landowski, L. Michalak, and W. J. Cuba?a, Reevaluating the prevalence and diagnostic subtypes of depressive disorders in epilepsy, Epilepsy Behav. 1 déc, vol.53, pp.15-24, 2015.

J. Seo, J. Lee, Y. W. Cho, S. Lee, J. Kim et al., Suicidality and Its Risk Factors in Korean People with Epilepsy: A MEPSY Study, J Clin Neurol Seoul Korea. janv, vol.11, issue.1, pp.32-41, 2015.

X. Tong, A. D. Lan, L. Zhou, X. Zhang, Q. Xiao et al., Validation of the Chinese version of the Neurological Disorders Depression Inventory for Epilepsy (C-NDDI-E) in West China, Epilepsy Behav. 1 juin, vol.47, pp.6-10, 2015.

Y. Guo, Z. Chen, Y. Zhang, Y. Ge, C. Shen et al., Reliability and validity of the Chinese version of the Neurological Disorders Depression Inventory for Epilepsy (C-NDDI-E), Epilepsy Behav. 1 avr, vol.45, pp.225-233, 2015.

J. Micoulaud-franchi, G. Barkate, T. Fonseca, A. Vaugier, L. Gavaret et al., One step closer to a global tool for rapid screening of major depression in epilepsy: Validation of the French NDDI-E, Epilepsy Behav. 1 mars, vol.44, pp.11-17, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01384022

. Owolabi, Depression in patients with epilepsy in Northwestern Nigeria: Prevalence and clinical correlates, Ann Afr Med [Internet]. déc, 2016.

S. Kuladee, T. Prachason, P. Srisopit, D. Trakulchang, A. Boongird et al., Prevalence of psychiatric disorders in Thai patients with epilepsy, Epilepsy Behav EB, vol.90, pp.20-24, 2019.

M. Lopez-gomez, J. Ramirez-bermudez, C. Campillo, A. L. Sosa, M. Espinola et al., Primidone is associated with interictal depression in patients with epilepsy, Epilepsy Behav. 1 mai, vol.6, issue.3, pp.413-419, 2005.

O. A. Ogunrin and Y. O. Obiabo, Depressive symptoms in patients with epilepsy: Analysis of self-rating and physician's assessment, Neurol India. 7 janv, vol.58, issue.4, p.565, 2010.

T. Zhao, M. Sun, P. Yu, G. Zhu, X. Tang et al., Evaluation of clinical aspects and quality of life as risk factors for depression in patients with epilepsy, Seizure. 1 juin, vol.21, issue.5, pp.367-70, 2012.

W. Peng, J. Ding, X. Li, L. Mao, and X. Wang, Clinical risk factors for depressive symptoms in patients with epilepsy, Acta Neurol Scand, vol.129, issue.5, pp.343-352, 2014.

B. Metternich, K. Wagner, F. Buschmann, R. Anger, and A. Schulze-bonhage, Validation of a German version of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E), Epilepsy Behav. 1 déc, vol.25, issue.4, pp.485-493, 2012.

C. Kui, P. Yingfu, X. Chenling, W. Wenqing, L. Xiuhua et al., What are the predictors of major depression in adult patients with epilepsy?, Epileptic Disord, vol.16, issue.1, pp.74-83, 2014.

A. J. Risti?, J. Pjevalica, G. Trajkovi?, A. Paroj?i?, A. Mihajlovi? et al., Validation of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) Serbian version, Epilepsy Behav. 1 avr, vol.57, pp.1-4, 2016.

K. A. Ayanda and D. Sulyman, The predictors of psychiatric disorders among people living with epilepsy as seen in a Nigerian Tertiary Health Institution, Niger Med J J Niger Med Assoc, vol.57, issue.1, pp.24-30, 2016.

L. S. Boylan, L. A. Flint, D. L. Labovitz, S. C. Jackson, K. Starner et al., Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy, p.4

C. Luoni, F. Bisulli, M. P. Canevini, G. D. Sarro, C. Fattore et al., Determinants of health-related quality of life in pharmacoresistant epilepsy: Results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments, Epilepsia, vol.52, issue.12, pp.2181-91, 2011.

L. Ridsdale, G. Wojewodka, R. E. Landau, S. Noble, A. Taylor et al., Characteristics associated with quality of life among people with drug-resistant epilepsy, J Neurol, vol.264, issue.6, pp.1174-84, 2017.

A. Grabowska-grzyb, J. J?drzejczak, E. Naga?ska, and U. Fiszer, Risk factors for depression in patients with epilepsy, Epilepsy Behav. 1 mars, vol.8, issue.2, pp.411-418, 2006.

M. E. Garcia, I. Garcia-morales, G. , and A. , Prevalence of depressive symptoms and their impact on quality of life in patients with drug-resistant focal epilepsy (IMDYVA study), Epilepsy Res. 1 févr, vol.110, pp.157-65, 2015.

W. Swinkels, Interictal Depression, Anxiety, Personality Traits, and Psychological Dissociation in Patients with Temporal Lobe Epilepsy (TLE) and Extra-TLE, 2006.

G. De-oliveira, A. Kummer, J. V. Salgado, E. J. Portela, S. R. Sousa-pereira et al., Psychiatric disorders in temporal lobe epilepsy: An overview from a tertiary service in Brazil, Seizure, vol.19, issue.8, pp.479-84, 2010.

V. Sanchez-gistau, L. Pintor, G. Sugranyes, E. Baillés, M. Carreño et al., Prevalence of interictal psychiatric disorders in patients with refractory temporal and extratemporal lobe epilepsy in Spain. A comparative study, Epilepsia, vol.51, issue.7, pp.1309-1322, 2010.

V. Sanchez-gistau, G. Sugranyes, E. Baillés, M. Carreño, A. Donaire et al., Is major depressive disorder specifically associated with mesial temporal sclerosis, Epilepsia, vol.53, issue.2, pp.386-92, 2012.

M. H. Nogueira, C. L. Yasuda, A. C. Coan, A. M. Kanner, and F. Cendes, Concurrent mood and anxiety disorders are associated with pharmacoresistant seizures in patients with MTLE, Epilepsia, vol.58, issue.7, pp.1268-76, 2017.

E. B. Gonçalves, T. De-oliveira-cardoso, C. L. Yasuda, and F. Cendes, Depressive disorders in patients with pharmaco-resistant mesial temporal lobe epilepsy, J Int Med Res. févr, vol.46, issue.2, pp.752-60, 2018.

S. J. Adams, T. J. O'brien, J. Lloyd, C. J. Kilpatrick, M. R. Salzberg et al., Neuropsychiatric morbidity in focal epilepsy, Br J Psychiatry. juin, vol.192, issue.6, pp.464-473, 2008.

A. Thapar, M. Roland, and G. Harold, Do depression symptoms predict seizure frequency-or vice versa?, J Psychosom Res, vol.59, issue.5, pp.269-74, 2005.

E. L. Reisinger and C. Diiorio, Individual, seizure-related, and psychosocial predictors of depressive symptoms among people with epilepsy over six months, Epilepsy Behav. 1 juin, vol.15, issue.2, pp.196-201, 2009.

L. B. Dehn, M. Pfäfflin, S. Brückner, M. T. Lutz, B. J. Steinhoff et al., Relationships of depression and anxiety symptoms with seizure frequency: Results from a multicenter follow-up study, Seizure. 1 déc, vol.53, pp.103-112, 2017.

Y. Xu, M. L. Hackett, N. Glozier, A. Nikpour, A. Bleasel et al., Frequency and predictors of psychological distress after a diagnosis of epilepsy: A community-based study, Epilepsy Behav, vol.75, pp.190-195, 2017.

S. Lee, J. Y. Jeon, S. No, H. Park, O. Kim et al., Factors contributing to anxiety and depressive symptoms in adults with new-onset epilepsy, Epilepsy Behav. 1 nov, vol.88, pp.325-356, 2018.

F. G. Gilliam, J. J. Barry, B. P. Hermann, K. J. Meador, V. Vahle et al., Rapid detection of major depression in epilepsy: a multicentre study, Lancet Neurol. mai, vol.5, issue.5, pp.399-405, 2006.

D. Goldberg, K. Bridges, D. , P. Grayson, and D. , Detecting anxiety and depression in general medical settings, BMJ, vol.297, issue.6653, pp.897-906, 1988.

M. Mohammadi, H. Davidian, A. Noorbala, H. Malekafzali, H. Naghavi et al., An epidemiological survey of psychiatric disorders in Iran, Clin Pract Epidemiol Ment Health, vol.1, issue.1, p.16, 2005.

D. C. Hesdorffer, L. Ishihara, L. Mynepalli, D. J. Webb, J. Weil et al., Epilepsy, suicidality, and psychiatric disorders: A bidirectional association, Ann Neurol. 1 août, vol.72, issue.2, pp.184-91, 2012.

C. B. Josephson, M. Lowerison, I. Vallerand, T. T. Sajobi, S. Patten et al., Association of Depression and Treated Depression With Epilepsy and Seizure Outcomes, Disponible sur, vol.74, 2017.

A. W. Thompson, J. W. Miller, W. Katon, N. Chaytor, and P. Ciechanowski, Sociodemographic and clinical factors associated with depression in epilepsy, Epilepsy Behav. avr, vol.14, issue.4, pp.655-60, 2009.

L. Scévola, M. Sarudiansky, A. Lanzillotti, S. Oddo, S. Kochen et al., To what extent does depression influence quality of life of people with pharmacoresistant epilepsy in Argentina?, Epilepsy Behav. 1 avr, vol.69, pp.133-141, 2017.

R. Joshi, M. Tripathi, P. Gupta, A. Goyal, and Y. K. Gupta, Depression in patients receiving pharmacotherapy for epilepsy: An audit in a tertiary care centre, Pharmacol Rep PR, vol.71, issue.5, pp.848-54, 2019.

M. Kim, Y. Kim, D. Kim, Y. Kwon, and O. , Major depressive disorder in epilepsy clinics: A meta-analysis, Epilepsy Behav. 1 juill, vol.84, pp.56-69, 2018.

L. Myers, M. Lancman, G. Vazquez-casals, M. Bonafina, K. Perrine et al., Depression and quality of life in Spanish-speaking immigrant persons with epilepsy compared with those in English-speaking US-born persons with epilepsy, Epilepsy Behav, vol.51, pp.146-51, 2015.

V. Villanueva, J. M. Girón, J. Martín, L. J. Hernández-pastor, J. Lahuerta et al., Quality of life and economic impact of refractory epilepsy in Spain: The ESPERA study, Neurol Engl Ed. 1 mai, vol.28, issue.4, pp.195-204, 2013.

M. Gandy, L. Sharpe, K. N. Perry, L. Miller, Z. Thayer et al., Rates of DSM-IV mood, anxiety disorders, and suicidality in Australian adult epilepsy outpatients: A comparison of wellcontrolled versus refractory epilepsy, Epilepsy Behav. 1 janv, vol.26, issue.1, pp.29-35, 2013.

P. Kwan, A. Arzimanoglou, A. T. Berg, M. J. Brodie, W. A. Hauser et al., Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies, Epilepsia, vol.51, issue.6, pp.1069-77, 2010.

A. Quiske, C. Helmstaedter, S. Lux, and C. E. Elger, Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis, Epilepsy Res. 3 avr, vol.39, issue.2, pp.121-126, 2000.

M. A. Elafros, E. Bui, and G. L. Birbeck, Medication side effects among people with epilepsy taking phenobarbital in Zambia, Epilepsy Res, vol.108, issue.9, pp.1680-1684, 2014.

D. Ding, Q. Zhang, D. Zhou, W. Lin, Q. Wu et al., Cognitive and mood effects of phenobarbital treatment in people with epilepsy in rural China: a prospective study, J Neurol Neurosurg Psychiatry. déc, vol.83, issue.12, pp.1139-1183, 2012.

D. F. Levinson and O. Devinsky, Psychiatric adverse events during vigabatrin therapy, Neurology, vol.53, issue.7, pp.1503-1514, 1999.

R. A. Grünewald, P. J. Thompson, R. Corcoran, Z. Corden, G. D. Jackson et al., Effects of vigabatrin on partial seizures and cognitive function, J Neurol Neurosurg Psychiatry. sept, vol.57, issue.9, pp.1057-63, 1994.

D. Chadwick, Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group, Lancet Lond Engl. 3 juill, vol.354, issue.9172, pp.13-22, 1999.

R. Kälviäinen, M. Aikiä, A. M. Saukkonen, E. Mervaala, and P. J. Riekkinen, Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study, Arch Neurol, vol.52, issue.10, pp.989-96, 1995.

C. A. Tassinari, R. Michelucci, P. Chauvel, J. Chodkiewicz, S. Shorvon et al., Doubleblind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy, Epilepsia. août, vol.37, issue.8, pp.763-771, 1996.

A. M. Kanner, J. Wuu, E. Faught, W. O. Tatum, A. Fix et al., A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events, Epilepsy Behav, vol.4, issue.5, pp.548-52, 2003.

M. Mula, D. C. Hesdorffer, M. Trimble, and J. W. Sander, The role of titration schedule of topiramate for the development of depression in patients with epilepsy, Epilepsia, vol.50, issue.5, pp.1072-1078, 2009.

M. Mula, M. R. Trimble, and J. Sander, The Role of Hippocampal Sclerosis in Topiramate-related Depression and Cognitive Deficits in People with Epilepsy, Epilepsia, vol.44, issue.12, pp.1573-1580, 2003.

M. Sharief, C. Viteri, E. Ben-menachem, M. Weber, R. Reife et al., Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy, Epilepsy Res, vol.25, issue.3, pp.217-241, 1996.

M. Baulac and I. E. Leppik, Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures, Epilepsy Res. 1 juill, vol.75, issue.2, pp.75-83, 2007.

M. J. Brodie, Zonisamide clinical trials: European experience, Seizure. déc, vol.13, 2004.

B. Chen, H. Choi, L. J. Hirsch, A. Katz, A. Legge et al., Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy, Epilepsy Behav, vol.76, pp.24-31, 2017.

E. Faught, Review of United States and European clinical trials of zonisamide in the treatment of refractory partial-onset seizures, Seizure. déc, vol.13, 2004.

E. Faught, R. Ayala, G. G. Montouris, and I. E. Leppik, Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures, Neurology, vol.57, issue.10, pp.1774-1783, 2001.

H. Goji and K. Kanemoto, The effect of perampanel on aggression and depression in patients with epilepsy: A short-term prospective study, Seizure. 1 avr, vol.67, pp.1-4, 2019.

G. L. Krauss, E. Perucca, P. Kwan, E. Ben-menachem, X. Wang et al., Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307, Epilepsia, vol.59, issue.4, pp.866-76, 2018.

A. Rohracher, G. Zimmermann, V. Villanueva, I. Garamendi, J. W. Sander et al., Perampanel in routine clinical use across Europe: Pooled, multicenter, observational data, Epilepsia, vol.59, issue.9, pp.1727-1766, 2018.

A. Morano, J. Fattouch, M. Albini, S. Casciato, M. Fanella et al., Perampanel as adjunctive therapy in highly refractory epilepsies: Real-world data from an Italian tertiary care epilepsy centre, J Neurol Sci. 15 juill, vol.390, pp.67-74, 2018.

F. Deleo, R. Quintas, K. Turner, G. Didato, E. Zambrelli et al., The impact of perampanel treatment on quality of life and psychiatric symptoms in patients with drug-resistant focal epilepsy: An observational study in Italy, Epilepsy Behav, vol.99, p.106391, 2019.

S. Noachtar, E. Andermann, P. Meyvisch, F. Andermann, W. B. Gough et al., Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures, Neurology. 19 févr, vol.70, issue.8, pp.607-623, 2008.

N. Delanty, J. Jones, and F. Tonner, Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: Open-label, noncomparative, multicenter, long-term follow-up study, Epilepsia, vol.53, issue.1, pp.111-120, 2012.

B. Abou-khalil, P. Hemdal, and M. D. Privitera, An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day?1 in adult patients with refractory epilepsy, Seizure. 1 avr, vol.12, issue.3, pp.141-150, 2003.

K. Heo, B. I. Lee, S. D. Yi, K. Huh, J. M. Kim et al., Efficacy and safety of levetiracetam as adjunctive treatment of refractory partial seizures in a multicentre open-label single-arm trial in Korean patients, Seizure. 1 juill, vol.16, issue.5, pp.402-411, 2007.

B. J. Steinhoff, E. R. Somerville, W. Van-paesschen, P. Ryvlin, and I. Schelstraete, The SKATE TM study: An open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy, Epilepsy Res. 1 août, vol.76, issue.1, pp.6-14, 2007.

M. J. Morrell, I. Leppik, J. French, J. Ferrendelli, J. Han et al., The KEEPER TM 1KEEPER is a trademark of UCB S.A.1 trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study, Epilepsy Res. 1 mai, vol.54, issue.2, pp.153-61, 2003.

B. S. Kang, H. J. Moon, Y. Kim, S. Lee, J. Chu et al., The long-term efficacy and safety of levetiracetam in a tertiary epilepsy centre, Epileptic Disord Int Epilepsy J Videotape. sept, vol.15, issue.3, pp.302-312, 2013.

D. Weintraub, R. Buchsbaum, S. R. Resor, and L. J. Hirsch, Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy, Epilepsy Behav. 1 févr, vol.10, issue.1, pp.105-115, 2007.

A. B. Kowski, F. Weissinger, V. Gaus, P. Fidzinski, F. Losch et al., Specific adverse effects of antiepileptic drugs -A true-to-life monotherapy study, Epilepsy Behav. 1 janv, vol.54, pp.150-157, 2016.

J. A. Cramer, K. De-rue, O. Devinsky, P. Edrich, and M. R. Trimble, A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials, Epilepsy Behav. 1 avr, vol.4, issue.2, pp.124-156, 2003.

G. K. Mbizvo, P. Dixon, J. L. Hutton, and A. G. Marson, The adverse effects profile of levetiracetam in epilepsy: a more detailed look, Int J Neurosci. sept, vol.124, issue.9, pp.627-661, 2014.

S. C. Sarangi, N. Kaur, and M. Tripathi, Assessment of psychiatric and behavioral adverse effects of antiepileptic drugs monotherapy: Could they have a neuroendocrine correlation in persons with epilepsy? Epilepsy Behav, vol.100, p.106439, 2019.

J. Lee, H. Song, Y. Hwang, H. Lee, C. Suh et al., Psychiatric Symptoms and Quality of Life in Patients with Drug-Refractory Epilepsy Receiving Adjunctive Levetiracetam Therapy, J Clin Neurol Seoul Korea. sept, vol.7, issue.3, pp.128-164, 2011.

M. Mazza, A. Martini, M. Scoppetta, and S. Mazza, Effect of levetiracetam on depression and anxiety in adult epileptic patients, Prog Neuropsychopharmacol Biol Psychiatry. 15 févr, vol.32, issue.2, pp.539-582, 2008.

A. Hagemann, T. W. May, E. Nieder, K. Witte-bölt, B. Pohlmann-eden et al., Quality of life, anxiety and depression in adult patients after add-on of levetiracetam and conversion to levetiracetam monotherapy, Epilepsy Res. 1 mars, vol.104, issue.1, pp.140-50, 2013.

I. E. Leppik, Tiagabine: the safety landscape, Epilepsia, vol.36, issue.6, pp.10-13, 1995.

B. M. Uthman, A. J. Rowan, P. A. Ahmann, I. E. Leppik, S. C. Schachter et al., Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial, Arch Neurol. janv, vol.55, issue.1, pp.56-62, 1998.

K. M. Fiest, J. Dykeman, S. B. Patten, S. Wiebe, G. G. Kaplan et al., Depression in epilepsy: A systematic review and meta-analysis, Neurology. 5 févr, vol.80, issue.6, pp.590-599, 2013.

C. Adelöw, T. Andersson, A. Ahlbom, and T. Tomson, Hospitalization for psychiatric disorders before and after onset of unprovoked seizures/epilepsy, Neurology. 7 févr, vol.78, issue.6, pp.396-401, 2012.

L. Tarsitani and J. M. Bertolote, Major depressive comorbidity in epilepsy as a reactive process to a chronic condition, Epilepsy Behav. 1 févr, vol.8, issue.1, pp.343-347, 2006.

S. Lee, J. Kim, J. Seo, Y. W. Cho, J. Lee et al., Predictors of quality of life and their interrelations in Korean people with epilepsy: A MEPSY study, Seizure, vol.23, issue.9, pp.762-770, 2014.

L. Yue, P. Yu, D. Zhao, D. Wu, G. Zhu et al., Determinants of quality of life in people with epilepsy and their gender differences, Epilepsy Behav. 1 déc, vol.22, issue.4, pp.692-698, 2011.

E. K. Johnson, J. E. Jones, M. Seidenberg, and B. P. Hermann, The Relative Impact of Anxiety, Depression, and Clinical Seizure Features on Health-related Quality of Life in Epilepsy, Epilepsia, vol.45, issue.5, pp.544-50, 2004.

J. I. Tracy, V. Dechant, M. R. Sperling, R. Cho, and D. Glosser, The association of mood with quality of life ratings in epilepsy, Neurology. 3 avr, vol.68, issue.14, pp.1101-1108, 2007.

U. C. Wieshmann and G. Baker, Efficacy and tolerability of anti-epileptic drugs-an internet study, Acta Neurol Scand, vol.135, issue.5, pp.533-542, 2017.

B. Gómez-arias, D. Crail-meléndez, R. López-zapata, and M. Ie, Severity of anxiety and depression are related to a higher perception of adverse effects of antiepileptic drugs, Seizure, vol.21, issue.8, pp.588-94, 2012.

A. M. Kanner, J. J. Barry, F. Gilliam, B. Hermann, and K. J. Meador, Depressive and anxiety disorders in epilepsy: Do they differ in their potential to worsen common antiepileptic drug-related adverse events, Epilepsia, vol.53, issue.6, pp.1104-1112, 2012.

B. Chen, H. Choi, L. J. Hirsch, A. Legge, R. Buchsbaum et al., Cross-sensitivity of psychiatric and behavioral side effects with antiepileptic drug use, Seizure. 1 nov, vol.62, pp.38-42, 2018.

J. W. Mcauley, N. Passen, C. Prusa, J. Dixon, S. Cotterman-hart et al., An evaluation of the impact of memory and mood on antiepileptic drug adherence, Epilepsy Behav. 1 févr, vol.43, pp.61-66, 2015.

O. Henning, M. I. Lossius, M. Lima, M. Mevåg, A. Villagran et al., Refractory epilepsy and nonadherence to drug treatment, Epilepsia Open, vol.4, issue.4, pp.618-641, 2019.

N. Hitiris, R. Mohanraj, N. J. Sills, G. J. Brodie, and M. J. , Predictors of pharmacoresistant epilepsy, Epilepsy Res. juill, vol.75, issue.2-3, pp.192-198, 2007.

G. De-oliveira, A. Kummer, J. V. Salgado, G. M. Filho, A. De et al., Suicidality in temporal lobe epilepsy: Measuring the weight of impulsivity and depression, Epilepsy Behav. 1 déc, vol.22, issue.4, pp.745-754, 2011.

M. Mula, A. Mcgonigal, J. Micoulaud-franchi, T. W. May, K. Labudda et al., Validation of rapid suicidality screening in epilepsy using the NDDIE, Epilepsia, vol.57, issue.6, pp.949-55, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01431269

M. P. Kerr, S. Mensah, F. Besag, . Toffol-b-de, A. Ettinger et al., International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy, Epilepsia, vol.52, issue.11, pp.2133-2141, 2011.

J. Hovorka, E. Herman, and I. Nemcová, Treatment of Interictal Depression with Citalopram in Patients with Epilepsy, Epilepsy Behav. 1 déc, vol.1, issue.6, pp.444-451, 2000.

K. Kühn, B. B. Quednow, M. Thiel, P. Falkai, W. Maier et al., Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants, Epilepsy Behav. 1 déc, vol.4, issue.6, pp.674-683, 2003.

A. M. Kanner, A. M. Kozak, and M. Frey, The Use of Sertraline in Patients with Epilepsy: Is It Safe?, Epilepsy Behav. 1 avr, vol.1, issue.2, pp.100-105, 2000.

R. Ribot, B. Ouyang, and A. M. Kanner, The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating?, Epilepsy Behav. 1 mai, vol.70, pp.5-9, 2017.

L. M. Specchio, A. Iudice, N. Specchio, L. Neve, A. Spinelli et al., Citalopram as treatment of depression in patients with epilepsy, Clin Neuropharmacol. juin, vol.27, issue.3, pp.133-139, 2004.

F. Gilliam and A. M. Kanner, Treatment of depressive disorders in epilepsy patients, Epilepsy Behav, vol.3, issue.5, pp.2-9, 2002.

J. Moon, K. Jung, J. Shin, J. Lim, J. Byun et al., Safety of tianeptine use in patients with epilepsy, Epilepsy Behav. 1 mai, vol.34, pp.116-125, 2014.

J. J. Barry, A. B. Ettinger, P. Friel, F. G. Gilliam, C. L. Harden et al., Consensus statement: The evaluation and treatment of people with epilepsy and affective disorders, Epilepsy Behav. 1 juill, vol.13, pp.1-29, 2008.

C. Johannessen-landmark, O. Henning, and S. I. Johannessen, Proconvulsant effects of antidepressants -What is the current evidence?, Epilepsy Behav. 1 août, vol.61, pp.287-91, 2016.

A. M. Kanner, Most antidepressant drugs are safe for patients with epilepsy at therapeutic doses: A review of the evidence, Epilepsy Behav. 1 août, vol.61, pp.282-288, 2016.

E. Spina, F. Pisani, and J. De-leon, Clinically significant pharmacokinetic drug interactions of antiepileptic drugs with new antidepressants and new antipsychotics, Pharmacol Res. 1 avr, vol.106, pp.72-86, 2016.

M. Mula, Anticonvulsants -antidepressants pharmacokinetic drug interactions: the role of the CYP450 system in psychopharmacology, Curr Drug Metab. oct, vol.9, issue.8, pp.730-737, 2008.

M. Mula, The pharmacological management of psychiatric comorbidities in patients with epilepsy, Pharmacol Res. 1 mai, vol.107, pp.147-53, 2016.

M. Mula, B. Schmitz, and J. W. Sander, The pharmacological treatment of depression in adults with epilepsy, Expert Opin Pharmacother. déc, vol.9, issue.18, pp.3159-68, 2008.

D. V. Vigo and R. J. Baldessarini, Anticonvulsants in the treatment of major depressive disorder: an overview, Harv Rev Psychiatry, vol.17, issue.4, pp.231-272, 2009.

C. B. Josephson, J. Engbers, N. Jette, S. B. Patten, T. T. Sajobi et al., Prescription trends and psychiatric symptoms following first receipt of one of seven common antiepileptic drugs in general practice, Epilepsy Behav. 1 juill, vol.84, pp.49-55, 2018.

M. E. Lunde, E. K. Lee, and K. G. Rasmussen, Electroconvulsive therapy in patients with epilepsy, Epilepsy Behav. 1 sept, vol.9, issue.2, pp.355-364, 2006.

M. Gandy, L. Sharpe, and K. N. Perry, Cognitive behavior therapy for depression in people with epilepsy: A systematic review, Epilepsia, vol.54, issue.10, pp.1725-1759, 2013.

M. Sajatovic, E. K. Johnson, R. T. Fraser, K. A. Cassidy, H. Liu et al., Self-management for adults with epilepsy: Aggregate Managing Epilepsy Well Network findings on depressive symptoms, Epilepsia, vol.60, issue.9, pp.1921-1952, 2019.